-
Something wrong with this record ?
Protein expression of ATP-binding cassette transporters ABCC10 and ABCC11 associates with survival of colorectal cancer patients
V. Krizkova, M. Dubova, S. Susova, O. Vycital, J. Bruha, M. Skala, V. Liska, O. Daum, P. Soucek,
Language English Country Germany
Document type Journal Article
NLK
ProQuest Central
from 1997-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-02-01 to 1 year ago
Public Health Database (ProQuest)
from 1997-02-01 to 1 year ago
- MeSH
- ATP-Binding Cassette Transporters metabolism MeSH
- Fluorouracil therapeutic use MeSH
- Colorectal Neoplasms drug therapy pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Recurrence, Local MeSH
- Survival Rate MeSH
- Follow-Up Studies MeSH
- Disease-Free Survival MeSH
- Prognosis MeSH
- Multidrug Resistance-Associated Proteins metabolism MeSH
- Antimetabolites, Antineoplastic therapeutic use MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
PURPOSE: This study investigated the prognostic importance of protein expression of ATP-binding cassette (ABC) transporters ABCC10 and ABCC11 in colorectal cancer. METHODS: Protein content of ABCC10 and ABCC11 was assessed in tumor tissue blocks of 140 colorectal cancer patients and associated with survival of patients with regard to 5-fluorouracil-based therapy. RESULTS: Low ABCC10 protein content in tumors increased hazard ratio of patient's death more than three times in comparison with high ABCC10-expressing tumors (P = 0.004). In contrast, the low ABCC11 content increased the hazard ratio of cancer recurrence in patients almost four times (P = 0.016). Analysis of patients treated with regimens based on 5-fluorouracil revealed that patients with low ABCC11 content in their tumors had shorter disease-free interval than those with higher content (P = 0.024). CONCLUSIONS: The present study shows for the first time that the protein expression of ABCC10 significantly associates with overall survival and the expression of ABCC11 with disease-free interval of colorectal cancer patients and provides strong impulse for further validation of their prognostic value in colorectal cancer.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023823
- 003
- CZ-PrNML
- 005
- 20240611151213.0
- 007
- ta
- 008
- 170720s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00280-016-3114-7 $2 doi
- 035 __
- $a (PubMed)27468921
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Krizkova, V $u Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 245 10
- $a Protein expression of ATP-binding cassette transporters ABCC10 and ABCC11 associates with survival of colorectal cancer patients / $c V. Krizkova, M. Dubova, S. Susova, O. Vycital, J. Bruha, M. Skala, V. Liska, O. Daum, P. Soucek,
- 520 9_
- $a PURPOSE: This study investigated the prognostic importance of protein expression of ATP-binding cassette (ABC) transporters ABCC10 and ABCC11 in colorectal cancer. METHODS: Protein content of ABCC10 and ABCC11 was assessed in tumor tissue blocks of 140 colorectal cancer patients and associated with survival of patients with regard to 5-fluorouracil-based therapy. RESULTS: Low ABCC10 protein content in tumors increased hazard ratio of patient's death more than three times in comparison with high ABCC10-expressing tumors (P = 0.004). In contrast, the low ABCC11 content increased the hazard ratio of cancer recurrence in patients almost four times (P = 0.016). Analysis of patients treated with regimens based on 5-fluorouracil revealed that patients with low ABCC11 content in their tumors had shorter disease-free interval than those with higher content (P = 0.024). CONCLUSIONS: The present study shows for the first time that the protein expression of ABCC10 significantly associates with overall survival and the expression of ABCC11 with disease-free interval of colorectal cancer patients and provides strong impulse for further validation of their prognostic value in colorectal cancer.
- 650 _2
- $a ABC transportéry $x metabolismus $7 D018528
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a protinádorové antimetabolity $x terapeutické užití $7 D000964
- 650 _2
- $a kolorektální nádory $x farmakoterapie $x patologie $7 D015179
- 650 _2
- $a přežití bez známek nemoci $7 D018572
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fluoruracil $x terapeutické užití $7 D005472
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a proteiny spojené s mnohočetnou rezistencí k lékům $x metabolismus $7 D027425
- 650 _2
- $a lokální recidiva nádoru $7 D009364
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Daumová, Magdaléna, $d 1989- $u Department of Pathology, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic. $7 xx0228260
- 700 1_
- $a Susova, S $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 323 00, Pilsen, Czech Republic.
- 700 1_
- $a Vycital, O $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 323 00, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Bruha, J $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 323 00, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Skala, M $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 323 00, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Liska, V $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 323 00, Pilsen, Czech Republic. Deparment of Surgery, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Daum, O $u Department of Pathology, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- 700 1_
- $a Soucek, P $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 323 00, Pilsen, Czech Republic. pavel.soucek@lfp.cuni.cz.
- 773 0_
- $w MED00001040 $t Cancer chemotherapy and pharmacology $x 1432-0843 $g Roč. 78, č. 3 (2016), s. 595-603
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27468921 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20240611151210 $b ABA008
- 999 __
- $a ok $b bmc $g 1239504 $s 984736
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 78 $c 3 $d 595-603 $e 20160728 $i 1432-0843 $m Cancer chemotherapy and pharmacology $n Cancer Chemother Pharmacol $x MED00001040
- LZP __
- $a Pubmed-20170720
